Centrex Strategic Partner Bio-Defense Research Group Wins Federal Contract
Centrex Strategic Partner Bio-Defense Research Group Wins Federal Contract
Tuesday , September 09, 2003 08:34 ET
TULSA, Okla., Sep 9, 2003 (BUSINESS WIRE) -- Centrex, Inc. (OTCBB:CNEX) today announced that its strategic partner, Bio-Defense Research Group, Inc. (BDRGI) of Mitchellville/Upper Marlboro, Md., won a contract valued at up to $4.5 million from the General Service Administration's Federal Supply Service. Centrex and BDRGI recently announced that they had entered into a strategic alliance to explore the joint applications, development and marketing of their complimentary technologies. Under the terms of the alliance, both companies will focus on their individual areas of expertise while investigating potential collaborations that would serve to deliver to the marketplace complete biological detection and filtering systems. The details of the BDRGI federal contract are unavailable at present.
In conjunction with the Companies' strategic alliance agreement, Centrex CEO Thomas R. Coughlin, Jr., M.D. was named to the Board of Directors of BDRGI. BDRGI CEO, Preston D. McGee, Sr., Ph.D. was named to the Technical Advisory Board of Centrex, and not to the Board of Directors as was previously announced.
Bio-Defense Research Group, Inc. is a privately held biomedical technology corporation that provides HVAC (Heating-Ventilation-Air Conditioning) solutions for commercial, government, military, educational, airline and transportation applications. The system, which destroys airborne biological agents as they move through heating and air conditioning ducts, was developed by The Johns Hopkins University Applied Physics Laboratory, Laurel, Md., and has been exclusively licensed to BDRGI for production.
BDRGI's novel product, Path-Away(R), is a one-of-a-kind proprietary technology that sets the standard for HVAC pathogen neutralization and destruction. BDRGI is developing a group of innovative products that will serve to accelerate the discovery and destruction of airborne pathogens. BDRGI's strengths include expertise in the fields of Biophysics, Occupational Health, Mechanical and Structural Engineering, Emergency Medicine, and Molecular Biology. For more information, visit www.BDRGI.com.
Centrex owns the exclusive worldwide license to develop, manufacture and market a system for detecting microbial contamination in air, food and water. The detection system is designed to be adaptable and easily tailored to detect a variety of bacterial and viral organisms by recognizing the unique DNA fingerprint of the organism. The proposed device is a simultaneous multi-channel detection system that is compact, fully automated and capable of monitoring the presence of biological agents in air, food and water. For further information, call Ron Wheet at 843-971-4848 or visit the Company website: www.centrexcorporation.com.
This press release contains some forward-looking statements. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Forward-looking statements in this document should be evaluated together with the many uncertainties that affect our business. Those uncertainties are discussed in the Company's SEC filings.
SOURCE: Centrex, Inc.
CONTACT: Centrex, Inc., Tulsa
Ron Wheet, 843-971-4848